Succinylcholine chloride Hydrate

水合氯琥珀胆碱

Report date: 2026/04/08 20:02:35
NME

Base Information

Drug NameSuccinylcholine chloride Hydrate
Drug Alias NameSuxamethonium chloride Hydrate水合氯化琥珀胆碱Suxamethonii chloridum Hydrate水合琥珀酰氯化胆碱水合氯琥珀胆硷 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholine receptor; alpha1/beta1/delta/gamma antagonistsMuscle relaxation agents
TargetsAcetylcholine receptor; alpha1/beta1/delta/gamma
Therapy Area/IndicationsMuscle HypotoniaMuscle HypertoniaMyalgia +[4] 
Global Approved IndicationsMuscle HypotoniaMuscle Hypertonia
Approved Indications in ChinaMuscle Hypertonia
Original Approved Country/TerritoryUnited States
Original Approved Date1952/08/20
Country/TerritoryUnited StatesUnited KingdomMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesEthypharm Uk LtdKyorin Pharmaceutical Co LtdIndiana University +[5] 
Inactive CompaniesHikma Pharmaceuticals Usa Inc
Active IndicationsMuscle HypotoniaMuscle HypertoniaMyalgia
Inactive IndicationsAnesthesia

Other Information

ATC CodeM03AB01
Related LinksWikipediaDrugBankKEGG